A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA)

BACKGROUND: Most patients suffering from a primary brain tumor (PBT) complain of chronic fatigue affecting their quality of life (QOL). We hypothesized that dexamphetamine sulfate, a psychostimulant drug, could improve fatigue in PBT patients. METHODS: A double-blind, phase III, multi-institutional,...

Descripción completa

Detalles Bibliográficos
Autores principales: Laigle-Donadey, Florence, Ducray, François, Boone, Matthieu, Diallo, Mamadou Hassimiou, Hajage, David, Ramirez, Carole, Chinot, Olivier, Ricard, Damien, Delattre, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212857/
https://www.ncbi.nlm.nih.gov/pubmed/32642669
http://dx.doi.org/10.1093/noajnl/vdz043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212857/
https://www.ncbi.nlm.nih.gov/pubmed/32642669
http://dx.doi.org/10.1093/noajnl/vdz043

Ejemplares similares